Research Output

2020 2020 2019 2019 2018 2018 2017 2017 2016 2016 2015 2015 2014 2014 2013 2013 2012 2012 2011 2011 0.0 0.0 0.2 0.2 0.4 0.4 0.6 0.6 0.8 0.8 1.0 1.0
Now showing 1 - 10 of 14
No Thumbnail Available
Publication

Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases

2009 , Umberto Capitanio , Shahrokh F. Shariat , Hendrik Isbarn , Alon Weizer , Mesut Remzi , Marco Roscigno , Eiji Kikuchi , Jay D. Raman , Christian Bolenz , Karim Bensalah , Theresa M. Koppie , Wassim Kassouf , FERNANDEZ ARANCIBIA, MARIO , Philipp Ströbel , Jeffrey Wheat , Richard Zigeuner , Cord Langner , Matthias Waldert , Mototsugu Oya , Charles C. Guo , Casey Ng , Francesco Montorsi , Christopher G. Wood , Vitaly Margulis , Pierre I. Karakiewicz

No Thumbnail Available
Publication

Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract

2010 , Richard Zigeuner , Shahrokh F. Shariat , Vitaly Margulis , Pierre I. Karakiewicz , Marco Roscigno , Alon Weizer , Eiji Kikuchi , Mesut Remzi , Jay D. Raman , Christian Bolenz , Karim Bensalah , Umberto Capitanio , Theresa M. Koppie , Wassim Kassouf , Kanishka Sircar , Jean-Jacques Patard , FERNANDEZ ARANCIBIA, MARIO , Christopher G. Wood , Francesco Montorsi , Philipp Ströbel , Jeffery C. Wheat , Andrea Haitel , Mototsugu Oya , Charles C. Guo , Casey Ng , Daher C. Chade , Arthur Sagalowsky , Cord Langner

No Thumbnail Available
Publication

Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

2016 , Francesco Soria , Shahrokh F. Shariat , Seth P. Lerner , Hans-Martin Fritsche , Michael Rink , Wassim Kassouf , Philippe E. Spiess , Yair Lotan , Dingwei Ye , FERNANDEZ ARANCIBIA, MARIO , Eiji Kikuchi , Daher C. Chade , Marko Babjuk , Arthur P. Grollman , George N. Thalmann

No Thumbnail Available
Publication

Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy

2010 , Jay D. Raman , Casey K. Ng , Douglas S. Scherr , Vitaly Margulis , Yair Lotan , Karim Bensalah , Jean-Jacques Patard , Eiji Kikuchi , Francesco Montorsi , Richard Zigeuner , Alon Weizer , Christian Bolenz , Theresa M. Koppie , Hendrik Isbarn , Claudio Jeldres , Wareef Kabbani , Mesut Remzi , Mathias Waldert , Christopher G. Wood , Marco Roscigno , Mototsuga Oya , Cord Langner , J. Stuart Wolf , Philipp Ströbel , FERNANDEZ ARANCIBIA, MARIO , Pierre Karakiewcz , Shahrokh F. Shariat

No Thumbnail Available
Publication

Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy

2012 , Jeffery C. Wheat , Alon Z. Weizer , J. Stuart Wolf , Yair Lotan , Mesut Remzi , Vitaly Margulis , Christopher G. Wood , Francesco Montorsi , Marco Roscigno , Eiji Kikuchi , Richard Zigeuner , Cord Langner , Christian Bolenz , Theresa M. Koppie , Jay D. Raman , FERNANDEZ ARANCIBIA, MARIO , Pierre Karakiewizc , Umberto Capitanio , Karim Bensalah , Jean-Jacques Patard , Shahrokh F. Shariat

No Thumbnail Available
Publication

Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density

2009 , Christian Bolenz , Shahrokh F. Shariat , FERNANDEZ ARANCIBIA, MARIO , Vitaly Margulis , Yair Lotan , Pierre Karakiewicz , Mesut Remzi , Eiji Kikuchi , Richard Zigeuner , Alon Weizer , Francesco Montorsi , Karim Bensalah , Christopher G. Wood , Marco Roscigno , Cord Langner , Theresa M. Koppie , Jay D. Raman , Shuji Mikami , Maurice Stephan Michel , Philipp Ströbel

No Thumbnail Available
Publication

What Is the Significance of Variant Histology in Urothelial Carcinoma?

2020 , Niyati Lobo , Shahrokh F. Shariat , Charles Chuanhai Guo , FERNANDEZ ARANCIBIA, MARIO , Wassim Kassouf , Ananya Choudhury , Jianjun Gao , Stephen B. Williams , Matthew D. Galsky , John A. Taylor , Morgan Roupret , Ashish M. Kamat

No Thumbnail Available
Publication

Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy

2009 , Marco Roscigno , Shahrokh F. Shariat , Vitaly Margulis , Pierre Karakiewicz , Mesut Remzi , Eiji Kikuchi , Cord Langner , Yair Lotan , Alon Weizer , Karim Bensalah , Jay D. Raman , Christian Bolenz , Charles C. Guo , Christopher G. Wood , Richard Zigeuner , Jeffrey Wheat , Wareef Kabbani , Theresa M. Koppie , Casey K. Ng , Nazareno Suardi , Roberto Bertini , FERNANDEZ ARANCIBIA, MARIO , Shuji Mikami , Masaru Isida , Maurice Stephan Michel , Francesco Montorsi

No Thumbnail Available
Publication

Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma

2009 , Eiji Kikuchi , Vitaly Margulis , Pierre I. Karakiewicz , Marco Roscigno , Shuji Mikami , Yair Lotan , Mesut Remzi , Christian Bolenz , Cord Langner , Alon Weizer , Francesco Montorsi , Karim Bensalah , Theresa M. Koppie , FERNANDEZ ARANCIBIA, MARIO , Jay D. Raman , Wassim Kassouf , Christopher G. Wood , Nazareno Suardi , Mototsugu Oya , Shahrokh F. Shariat

To assess the association of lymphovascular invasion (LVI) with cancer recurrence and survival in a large international series of patients treated with radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC). Patients and Methods Data were collected on 1,453 patients treated with RNU at 13 academic centers and combined into a relational database. Pathologic slides were rereviewed by genitourinary pathologists according to strict criteria. LVI was defined as presence of tumor cells within an endothelium-lined space. Results LVI was observed in 349 patients (24%). Proportion of LVI increased with advancing tumor stage, high tumor grade, presence of tumor necrosis, sessile tumor architecture, and presence of lymph node metastasis (all P < .001). LVI was an independent predictor of disease recurrence and survival (P < .001 for both). Addition of LVI to the base model (comprising pathologic stage, grade, and lymph node status) marginally improved its predictive accuracy for both disease recurrence and survival (1.1%, P = .03; and 1.7%, P < .001, respectively). In patients with negative lymph nodes and those in whom a lymphadenectomy was not performed (n = 1,313), addition of LVI to the base model improved the predictive accuracy of the base model for both disease recurrence and survival by 3% (P < .001 for both). In contrast, LVI was not associated with disease recurrence or survival in node-positive patients (n = 140). Conclusion LVI was an independent predictor of clinical outcomes in nonmetastatic patients who underwent RNU for UTUC. Assessment of LVI may help identify patients who could benefit from multimodal therapy after RNU. After confirmation, LVI should be included in staging of UTUC.

No Thumbnail Available
Publication

Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration

2009 , Nicholas J. Hellenthal , Shahrokh F. Shariat , Vitaly Margulis , Pierre I. Karakiewicz , Marco Roscigno , Christian Bolenz , Mesut Remzi , Alon Weizer , Richard Zigeuner , Karim Bensalah , Casey K. Ng , Jay D. Raman , Eiji Kikuchi , Francesco Montorsi , Mototsugu Oya , Christopher G. Wood , FERNANDEZ ARANCIBIA, MARIO , Christopher P. Evans , Theresa M. Koppie